The importance of N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2) as a receptor determinant for bovine coronavirus (BCV) on cultured cells was analysed. Pretreatment of MDCK I (Madin Darby canine kidney) cells with neuraminidase or acetylesterase rendered the cells resistant to infection by BCV. The receptors on a human (CaCo-2) and a porcine (LLC-PK1) epithelial cell line were also found to be sensitive to neuraminidase treatment. The susceptibility to infection by BCV was restored after resialylation of asialo-MDCK i cells with Neu5,9Ac2. Transfer of sialic acid lacking a 9-O-acetyl group was ineffective in this respect. These results demonstrate that 9-0acetylated sialic acid is used as a receptor determinant by BCV to infect cultured cells. The possibility is discussed that the initiation ofa BCV infection involves the recognition of different types of receptors, a first receptor for primary attachment and a second receptor to mediate the fusion between the viral envelope and the cellular membrane.
Introduction
Bovine coronavirus (BCV) is an enteropathogenic coronavirus causing severe diarrhoea in newborn calves (Siddell et al., 1983) . The mechanisms by which BCV infects cells and causes disease are not well characterized, nor are the factors known which determine the host and tissue specificity. The cellular receptor which is a crucial determinant of the tropism of several viruses, is not known in the case of BCV.
The only receptor for coronaviruses which has been identified so far on susceptible cells is that for a murine coronavirus, mouse hepatitis virus (MHV). Strain MHV-A59 has been shown to bind to a 100K to 110K protein present in membranes from hepatocytes and enterocytes of susceptible mice, but absent in comparable preparations from resistant mice (Boyle et al., 1987) . A monoclonal anti-receptor antibody that prevents MHV from infecting susceptible mouse cells was used for affinity purification of the receptor (Williams et al., 1990) , which has been shown to be a member of the carcinoembryonic antigen family of glycoproteins (Williams et al., 1991) . It is not known whether a related receptor is required for other coronaviruses to initiate infection. BCV and MHV-A59 have quite different binding activities; they differ not only in the spectrum of cells susceptible to infection but also in their interactions with erythrocytes. MHV-A59 is unable to agglutinate erythrocytes (Yokomori et al., 1989) , whereas BCV is a potent haemagglutinating agent (Sato et al., 1977) .
The crucial step in the elucidation of the erythrocyte receptors for BCV was the finding that BCV and influenza C virus have a receptor-destroying enzyme in common. Influenza C virus inactivates its own receptors by a virus-encoded acetylesterase, which releases Oacetyl residues from position C9 of N-acetyl-9-Oacetylneuraminic acid (Neu5,9Ac2) (Herder et al., 1985 b) . The same enzyme is also present on the surface of BCV (Vlasak et al., 1988b; Schultze et al., 1991a) . Pretreatment of erythrocytes with virions or purified acetylesterase renders the cells resistant against agglutination by BCV (Vlasak et al., 1988a; Schultze et al., 1990) . Restoration of coronavirus receptors was achieved by resialylation of erythrocytes with Neu5,9Ac2 (Schultze et al., 1990) . These results indicated that Neu5,9Ac2 is a receptor determinant for attachment of BCV to erythrocytes. However, the relevance of this interaction for infection of cells has remained unknown.
In the present report we provide evidence that Neu5,9Ac2 serves as a receptor determinant for BCV on cultured cells. The receptor can be inactivated by pretreatment with acetylesterase or neuraminidase. Resialylation of cells with Neu5,9Ac2 restores the susceptibility to virus infection. This finding is discussed in the context of the protein receptor described for MHV-A59.
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Methods
Cells. MDCK I cells, a subline of Madin Darby canine kidney cells, were maintained as described previously (Schultze et al., 1991 a) .
CaCo-2 cells were purchased from ATCC and grown in RPMI medium containing 10~ foetal calf serum (FCS). LLC-PK 1 cells were kindly provided by Dr D. Jans (Max Planck Institut ffir Biophysik, Frankfurt, Germany) and grown in Dulbecco's medium containing 10~ FCS.
Virus. Strain L-9 of BCV and strain Johannesburg/1/66 (JHB/1/66) of influenza C virus were grown on MDCK I cells as described previously (Schultze et al., 1990) . Strain WSN of influenza A virus was grown in 11-day-old embryonated chicken eggs. Virus was harvested from the allantoic fluid 2 days after inoculation.
Virus infections. For the inactivation and regeneration of virus
receptors, cells were grown in 35 mm plastic Petri dishes and infected with virus (about 10 TCIDso/cell). After an adsorption time of 20 min at room temperature, cells were washed with PBS and incubated for 10 min at room temperature with rabbit antiserum (diluted 1 : 100 with PBS) directed against the virus used for infection. Following two washes with PBS, the cells were incubated for 24 h at 37 °C with MEM containing trypsin (1 ktg/ml). The efficiency of infection was judged by the yield of virus released into the medium as indicated by the haemagglutination activity of the cell supernatant.
Haemagglutination assays. These were performed as described previously (Herrler et al., 1985a) . The haemagglutination titre (HA units) indicates the reciprocal value of the maximum dilution that caused complete agglutination.
Purification of the acetylesterase of BCV. The purification of the acetylesterase of BCV has been described previously (Schultze et al., 1991 a) . The amount of acetylesterase required to release 1 Bmol of acetate from paranitrophenyl acetate in 1 rain at 25 °C was defined as 1 unit of enzyme.
Inactivation of cellular receptors. Cells grown on culture dishes (35 mm) were washed twice with PBS and incubated for 60 min at 37 °C with 200 p.1 of PBS in the presence of either neuraminidase from Clostridiumperfringens [ 150 milli units (mU)], acetylesterase from BCV (1.3 U), or trypsin (50 ~tg). After being washed with PBS, the cells were infected with virus. In some experiments, neuraminidase-treated cells were resialylated prior to infection.
Resialylation of cultured cells. After pretreatment with neuraminidase to remove cellular receptors for BCV, cells were washed twice with PBS. Following addition of 5 mU of Galfll,4GlcNAc ct2,6-sialyltransferase and the amount of CMP-sialic acid indicated, the cells were incubated at 37 °C for various times. Prior to use, the sialyltransferase was freed of detergent as described previously (Schultze et aL, 1990) .
Cells were again washed twice and infected with virus.
Materials. Rat livel Galfll,4GlcNAc ct2,6-sialyltransferase were purchased from Boehringer Mannheim; CMP-N-acetylneuraminic acid (CMP-Neu5A'e) and C. perfringens neuraminidase from Sigma; CMP-Neu5,9Ac2 was kindly provided by Drs R. Brossmer and H. J. Gross, Heidelberg, Germany.
Results
Inactivation of cell surface receptors by neuraminidase
As BCV uses Neu5,9Ac2 as a receptor determinant for attachment to erythrocytes (Vlasak et al., 1988a;  Schultze et al., 1990) , the importance of this type of sialic acid for the infection of cells was analysed. MDCK I cells were pretreated with neuraminidase from C. perfringens to remove sialic acid from the surface glycoproteins and glycolipids prior to infection with BCV. The effect of the enzyme on virus replication was determined 24 h postinfection (p.i.) by measuring the haemagglutinating activity of the virus released into the medium. As shown in Fig. 1 , the yield of virus obtained from MDCK I cells was reduced after pretreatment with neuraminidase. When the enzyme was used in an amount as high as 40 mU, the cells became resistant against infection by BCV as shown by the lack of haemagglutination activity in the supernatant. This result indicates that sialic acid present on the cell surface is essential for BCV to initiate an infection. We were interested to find out whether sialic acid also plays an important role in the infection of cell types other than MDCK I cells. Human colon carcinoma cells, CaCo-2, and porcine kidney cells, LLC-PK1, are both susceptible to BCV, although the virus yield is not as high as that from MDCK I cells. These different cell types were pretreated with neuraminidase to remove sialic acid from the cellular surface prior to infection with BCV. The enzyme treatment had the same effect on LLC-PK1 and CaCo-2 cells as described above for MDCK I cells (Table 1) . The virus yield from neuraminidase-treated cells was reduced fourfold in the case of CaCo-2 cells and more than eightfold with LLC-PK1 cells. These results indicate that sialic acid is necessary for BCV to infect cultured cells.
Inactivation of cell surface receptors by acetylesterase
The receptor-destroying enzyme of BCV inactivates the Neu5,9Ac2-containing receptors on erythrocytes (Vlasak et al., 1988a; Schultze et al., 1991a) . We analysed whether this enzyme is able to inactivate receptors for BCV on MDCK I cells.
In parallel experiments, we compared the effect of acetylesterase and neuraminidase on the cellular receptors for BCV as well as for influenza C virus (JHB/1/66), which requires Neu5,9Ac2 to initiate an infection (Herrler & Klenk, 1987) , and for influenza A virus (WSN), which recognizes Neu5Ac as a receptor determinant. After pretreatment with neuraminidase, no virus was detectable by haemagglutination titration of the supernatant of MDCK I cells infected with either of the three viruses ( In contrast to the enzymes mentioned above, treatment of cells with trypsin had no effect on the ability of the three viruses to infect MDCK I cells.
Restoration of cellular receptors by resialylation
To provide further evidence that Neu5,9Ac2 is the crucial receptor determinant for BCV on cultured cells, resialylation experiments were carried out. This method has already been used to characterize the receptors for influenza C virus and BCV on erythrocytes (Rogers et al., 1986; Schultze et al., 1990) . Cells were pretreated with neuraminidase to remove sialic acid from the cellular surface. The asialo cells were resialylated using purified rat liver Galfll,4GlcNAc ~2,6-sialyltransferase and activated sialic acid (CMP-Neu5Ac or CMP-Neu5,9Ac2, respectively). Neither BCV nor influenza C virus was able to infect MDCK I cells resialylated to contain Neu5Ac on the surface (Table 3) . As expected for influenza A virus, strain WSN could infect cells resialylated with Neu5Ac, but not cells containing Neu5,9Ac2. In contrast, replication of BCV and influenza C virus was observed following attachment of Neu5,9Acz to cell surface glycoproteins of asialo cells, whereas cells containing Neu5Ac were found to be resistant to infection.
In a previous study we have shown that influenza C virus requires less Neu5,9Acz on the cell surface for agglutination of erythrocytes than BCV (Schultze et al., 1990) . We were interested to find out whether such a difference is also observed with cultured cells. Resialylation experiments were carried out with different amounts of CMP-Neu5,9Ac2 to obtain cells with different amounts of 9-O-acetylated sialic acid on the surface. As shown in Fig. 2 , infection by BCV was detected when 0.5 nmol CMP-Neu5,9Ac2 had been used for resialylation of MDCK I cells. The minimum concentration of CMP-Neu5,9Acz required to render asialo cells susceptible to influenza C virus infection was more than 1 nmol. This result suggests that BCV is more efficient in utilizing low amounts of Neu5,9Ac2 for the initiation of an infection. However, when 10 nmol of CMP-Neu5,9Ac2 had been used for the resialylation of cells, the yield of influenza C virus was 50~ cohapared to untreated control cells, whereas in the case of BCV a yield of only i2.5~ was obtained. Thus, an optimum infection by influenza C virus requires less sialic acid on the cell surface than does a BCV infection. The same observation was made when the time course of the resialylation reaction was analysed. For this purpose, asialo cells were incubated with sialyltransferase and 20 nmol of CMP-Neu5,9Ac2, for various times. As shown in Fig. 3 , the time required to restore enough Neu5,9Ac2-containing receptors on the cell surface for a detectable infection was roughly the same for both BCV and influenza C virus (5 to 10 min). An incubation period of 20 min was sufficient to transfer enough Neu5,9Ac2 to the cell surface to obtain a 50~ yield of influenza C virus compared to control cells. For BCV, even after an incubation time of 40 min, the amount of virus released from resialylated cells was only 10~ of the virus yield obtained from untreated cells. Because of difficulties in synthesizing CMP-Neu5,9Ac2, only a limited amount of this compound was available for our experiments. Therefore, we were not able to determine the amount of CMP-Neu5,9Ac2 required for a complete restoration of the receptors for BCV.
Discussion
The available information about the cellular receptor for BCV is based on work with erythrocytes (Vlasak et al., 1988a; Schultze et al., 1990) . These studies have shown that Neu5,9Ac2 is a receptor determinant for BCV, but the relevance of these findings for BCV infection was unknown.
The results presented above provide evidence that Neu5,9Ac2 is the primary receptor determinant on cells which are infected by BCV: (i) pretreatment of cells with acetylesterase or neuraminidase rendered cells resistant against infection and (ii) resialylation of asialo cells with Neu5,9Ac2 restored the susceptibility to virus infection. Thus, binding to Neu5,9Ac2-containing receptors enables BCV to initiate an infection.
The enzyme used for generation of receptors on MDCK cells is specific for resialylation of proteins. Therefore, glycoproteins can serve as cellular receptors for BCV. However it cannot be dismissed that BCV is able to interact also with glycolipids, as shown for Sendai virus (Markwell et al., 1981) . This possibility has to be considered also for BCV, because bovine brain gangliosides have been shown to act as haemagglutination inhibitors (Vlasak et al., 1988a) . For convenience we have used only a2,6-sialyltransferase to restore receptors for BCV on asialo cells. Our results should not be interpreted as indicating a linkage specificity in the recognition of receptors. It is possible that BCV recognizes 9-O-acetylated sialic acid in other linkage types such as an a2,3 linkage as well as in an ~2,6 linkage.
Influenza A and B viruses, some paramyxoviruses as well as several other viruses use Neu5Ac for binding to cells. So far BCV and influenza C virus are the only viruses reported to use 9-O-acetylated sialic acid for the initiation of infection. In addition to the receptor determinant, both viruses have an acetylesterase in common, which acts as a receptor-destroying enzyme. This similarity is surprising considering the fact that BCV is a positive-stranded RNA virus and influenza C virus a negative-stranded RNA virus. There are, however, differences in the distribution of the biological activities among the surface proteins. The HEF protein of influenza C virus is a haemagglutinin, an esterase and a fusion factor (reviewed by Herder & Klenk, 1991) . In the case of BCV, these activities are distributed among two glycoproteins. The S protein has fusion activity (Payne & Storz, 1988) and is the major haemagglutinin (Schultze et al., 1991b) . The HE protein is also a haemagglutinin (King et al., 1985) . It has the same binding specificity, but it is much less efficient in this respect than the S protein requiring a higher amount of Neu5,9Ac2 for agglutination of cells (Schultze et al., 1991b) . Therefore, HE may function primarily as a receptor-destroying enzyme.
The target tissue for influenza C virus is the epithelium of the upper respiratory tract. BCV is able to infect cells of the respiratory tract as well as intestinal cells. These viruses appear to grow preferentially in epithelial cells. Our results imply that these cells contain 9-O-acetylated sialic acid. Whether the presence of Neu5,9Ac2 is a determinant of the tissue tropism of BCV remains to be shown.
The murine coronavirus MHV replicates in the intestinal and respiratory epithelium, the liver, and some strains replicate also in the brain and spinal cord of susceptible mice. A l l0K receptor protein has been isolated from the brush border membrane of hepatocytes and enterocytes (Williams et al., 1990) and was shown to belong to the carcinoembryonic antigen family of glycoproteins (Williams et al., 1991) . In the case of MHV it is not known whether Neu5,9Ac2 is involved in virus binding or infection of cells. On the other hand, it is also not known whether a protein similar to the 110K protein plays a role in the infection of cells by BCV.
In comparing BCV and MHV, the question arises whether two serologically related viruses are using two different receptors. This appears to be unlikely. A possible explanation might be that there are two receptors which are involved in the initiation of an infection. A first receptor may mediate the primary attachment of virus. Neu5,9Ac2 is a good candidate for this kind of binding, because it is a more frequent component of the cells surface than a specific protein. A second receptor might be required for a closer contact between virus and cell to facilitate or even induce the fusion of the membranes. In the case of influenza virus, a conformational change of the HA protein takes place at acidic pH, which is believed to induce the fusion (Skehel et al., 1982) . Fusion caused by BCV is not dependent on a low pH (Payne & Storz, 1988) . Therefore, the interaction with a second receptor might be required for the exposure of a fusogenic epitope.
This model does not imply that the two proposed receptors have to be of equal importance for all strains. For example, increasing the efficiency in the recognition of the second receptor may render the first receptor dispensable for infection. This may be true for some murine coronaviruses. Several strains have both acetylesterase and haemagglutinating activity, which suggests that they recognize Neu5,9Ac2 (Sugiyama & Amano, 1980) . Other MHV strains such as A59 or JHM have no haemagglutinating activity and they either lack an esterase or have only low amounts of it (Yokomori et al., 1989) . Maybe for the latter viruses recognition of the ll0K receptor is sufficient for the initiation of an infection. However, it should be kept in mind that these viruses might also have an affinity for Neu5,9Ac2containing receptors despite the lack of haemagglutinating activity. Interestingly, following passage of strain JHM though neural cell cultures, viral isolates were obtained which differed from the original virus by the expression of high levels of HE protein and by an increased size of the S protein (Taguchi et al., 1986) . There is no information about the receptor-binding activity of these isolates. These findings suggest, however, that the importance of Neu5,9Acz for an MHV infection may vary between cell types.
A second receptor, in addition to Neu5,9Ac2-containing surface components, may also play a role in the case of BCV. Support for this concept may come from the observation that inactivation and restoration of sialic acid-containing receptors was detectable only by following the stringent conditions of the infection protocol: (i) a short period of virus adsorption at room temperature, (ii) a short resialylation time at 37 °C and (iii) inactivation of residual virus by neutralizing antibodies. Similar experimental difficulties have been reported for influenza A viruses, which do not appear to require a second receptor for virus infection (Carroll & Paulson, 1985) . However, endogenous restoration of virus receptors was found to be less critical in the case of influenza C virus compared to BCV (B. Schultze, unpublished observation). Furthermore, despite the lower efficiency in recognizing Neu5,9Ac2 on erythrocytes, BCV was somewhat more efficient than influenza C virus in utilizing low amounts of 9-O-acetylated sialic acid for a low level of infection (Fig. 2 ). Influenza C virus, however, required less Neu5,9Ac2 to reach optimum values of infection. This finding is compatible with the existence of a second receptor, which may interact with BCV following primary virus attachment to sialic acidcontaining receptors. If such a receptor exists, it differs from the receptor for MHV-A59 in species specificity. Whereas the latter receptor is restricted to murine cells, BCV is able to infect cells from different species, e.g. canine (MDCK I), porcine (LLC-PK1) and human cells (HRT-18, CaCo-2). Future work will be aimed at the identification of a potential second receptor for BCV.
